¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"multiple infection"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
localized infection
±¹¼Ò°¨¿°
lymphogenous infection
¸²ÇÁ¼º°¨¿°
lytic infection
¿ë±Õ°¨¿°
midpalmar space infection
Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
milk-borne infection
¿ìÀ¯¸Å°³°¨¿°
mixed infection
È¥ÇÕ°¨¿°
mock infection
¸ðÀǰ¨¿°½ÇÇè
mycotic infection
°õÆÎÀ̰¨¿°, Áø±Õ°¨¿°
mass infection
Áý´Ü°¨¿°
neonatal infection
½Å»ý¾Æ°¨¿°
nosocomial infection
º´¿ø³»°¨¿°
nosocomial infection control
º´¿ø³»°¨¿°°ü¸®
natural infection
ÀÚ¿¬°¨¿°
occult infection
ÀáÀç°¨¿°
opportunistic infection
±âȸ°¨¿°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
infection immunity
°¨¿°¸é¿ª
infection route
°¨¿°°æ·Î
infection source
°¨¿°¿ø, Àü¿°¿ø
infection control study
°¨¿°°ü¸®Á¶»ç
infection control surveillance
°¨¿°°ü¸®°¨½Ã
insect-borne infection
°ïÃæ¸Å°³°¨¿°
intercurrent infection
º´¹ß°¨¿°
introduced infection
µµÀÔ°¨¿°
latent infection
Àẹ°¨¿°
local infection
±¹¼Ò°¨¿°
localized infection
±¹¼Ò°¨¿°
lymphogenous infection
¸²ÇÁ°¨¿°
lytic infection
¿ë±Õ¼º°¨¿°
mass infection
Áý´Ü°¨¿°
midpalmar space infection
Áß°£¼Õ¹Ù´Ú°ø°£°¨¿°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
infection, mycotic
Áø±Õ°¨¿°
infection, natural
ÀÚ¿¬°¨¿°
infection, nosocomial
¿ø³»°¨¿°, º´¿ø³»°¨¿°
infection, odontogenic
Ä¡¼º°¨¿°
infection, opportunistic
±âȸ°¨¿°
infection, oral
±¸°°¨¿°
infection, oral focal
±¸°º´¼Ò°¨¿°
infection, otic
ÀÌ(¼º)°¨¿°
infection, persistent
Áö¼Ó°¨¿°
infection, polymicrobial
º¹¼ö±Õ°¨¿°, º¹¼ö¹Ì»ý¹°°¨¿°
infection, primary
ÀÏÂ÷°¨¿°
infection, secondary
ÀÌÂ÷°¨¿°
infection, slow virus
Áö¹ß¹ÙÀÌ·¯½º°¨¿°
infection, soil-borne
Åä¾ç¸Å°³°¨¿°
infection, subclinical
¹«Áõ»ó°¨¿°, ºÒÇö°¨¿°
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
multiple neuritis
´Ù¹ß¼º ½Å°æ¿°(¡ãêÌèæú).
multiple neurofibroma
´Ù¹ß¼º ½Å°æ ¼¶À¯Á¾
multiple neurofibromatosis
´Ù¹ß½Å°æ¼¶À¯Á¾ Áõ(ÒýÛ¡ãêÌèàéë«ðþñø).
multiple neurofibromatosis
´Ù¹ß½Å°æ¼¶À¯Á¾Áõ(¡ãêÌèàéë«ðþñø)
multiple neurofibromatosis
´Ù¹ß½Å°æ¼¶À¯Á¾Áõ(ÒýÛ¡ãêÌèàéë«ðþñø)
multiple neuroma = neuromatosis
´Ù¹ß¼º ½Å°æÁ¾(¡ãêÌèðþ)
multiple neuroma =neuromatosis
´Ù¹ß¼º ½Å°æÁ¾(¡ãêÌèðþ).
multiple neuroma =neuromatosis
´Ù¹ß¼º ½Å°æÁ¾(¡ãêÌèðþ)
multiple neuroma syndrome
´Ù¹ß¼º ½Å°æÁ¾ÁõÈıº(ÒýÛ¡àõãêÌèðþñøý¦ÏØ).
multiple nodular goiter
´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(ÒýÛ¡àõÌ¿ï½àõË£ßÒàÍðþ).
multiple nodular goiter
´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(¡Ì¿ï½àõË£ßÒàÍðþ)
multiple nodular goiter
´Ù¹ß¼º °áÀý¼º °©»ó¼±Á¾(´Ù¹ß¼º°áÀý¼º°©»ó¼±Á¾).
multiple organ dysfunction
multiple overlapping thin slab acquisition (MOTSA)
´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
multiple paramyoclonus
´Ù¹ß¼º ±Ù°£´ë°æ·Ã(ÒýÛ¡àõÐÉÊàÓÛÌâÕý).
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
7
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½